日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence

撤稿声明:HIF1α高核表达与LIMD1和VHL失活协同作用,预示膀胱癌患者预后最差:与砷暴露流行率相关

Basu, Mukta; Chatterjee, Amvrin; Chakraborty, Balarko; Chatterjee, Essha; Ghosh, Sabnam; Samadder, Sudip; Pal, Dilip Kumar; Roy, Anup; Chakrabarti, Jayanta; Ghosh, Amlan; Panda, Chinmay Kumar

Anticancer activity of RM-3-22: a TAZQ-based hydroxamic acid derivative targeting NSCLC in vitro and in vivo

RM-3-22 的抗癌活性:一种基于 TAZQ 的羟肟酸衍生物,可体外和体内靶向非小细胞肺癌

Essha Chatterjee # ,Ram Sharma # ,Biswajit Dey ,Hoshiyar Singh ,Aliva Naik ,Anjesh Khan ,Santanu Basak ,Ankush Bansode ,Ritika Sachdeva ,Anamika Sharma ,Rahul Kumar ,Pradeep Naik ,Pankaj Kumar Singh ,Kunal Nepali ,Santosh Kumar Guru

Antiproliferative Potential of Gloriosine: A Lead for Anticancer Drug Development

Gloriosine的抗增殖潜力:抗癌药物研发的先导化合物

Goel, Bharat; Dey, Biswajit; Chatterjee, Essha; Tripathi, Nancy; Bhardwaj, Nivedita; Kumar, Sanjay; Guru, Santosh Kumar; Jain, Shreyans K

Identification and Evaluation of Apoptosis-Inducing Activity of Ipomone from Ipomoea nil: A Novel, Unusual Bicyclo-[3.2.1] Octanone Containing Gibberic Acid Diterpenoid

从牵牛花中鉴定并评价番薯酮的凋亡诱导活性:一种新型的、不寻常的含赤霉素的双环[3.2.1]辛酮类化合物

Goel, Bharat; Chatterjee, Essha; Dey, Biswajit; Tripathi, Nancy; Bhardwaj, Nivedita; Khattri, Arun; Guru, Santosh Kumar; Jain, Shreyans K

High nuclear expression of HIF1α, synergizing with inactivation of LIMD1 and VHL, portray worst prognosis among the bladder cancer patients: association with arsenic prevalence

HIF1α的高核表达,与LIMD1和VHL的失活协同作用,预示着膀胱癌患者预后最差:与砷中毒流行率相关

Basu, Mukta; Chatterjee, Amvrin; Chakraborty, Balarko; Chatterjee, Essha; Ghosh, Sabnam; Samadder, Sudip; Pal, Dilip Kumar; Roy, Anup; Chakrabarti, Jayanta; Ghosh, Amlan; Panda, Chinmay Kumar

Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms

利用纳米药物递送平台探索克服P-糖蛋白介导的多药耐药性乳腺癌的新途径

Famta, Paras; Shah, Saurabh; Chatterjee, Essha; Singh, Hoshiyar; Dey, Biswajit; Guru, Santosh Kumar; Singh, Shashi Bala; Srivastava, Saurabh